The Clinical Resource Center is where you will find clinical evidence from peer-reviewed publications, educational webinars, and case studies showcasing real-world clinical applications of Zio.
“Unrestricted research grants received from iRhythm San Francisco, CA, USA, NUUBO Smart Solutions Technologies, SL, Madrid and Bardy Diagnostics Inc., Seattle, WA, USA.”
“iRhythm Technologies, Inc. provided financial support for the data annotation in this work. M.H. and C.B. are employees of iRhythm Technologies, Inc. A.Y.H. was funded by an NVIDIA fellowship. G.H.T. received support from the National Institutes of Health (K23 HL135274). The only financial support provided by iRhythm Technologies, Inc. for this study was for the data annotation. Data analysis and interpretation was performed independently from the sponsor. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.”
Author affiliations and conflict of interest: Ms. Lenane is an employee of iRhythm Technologies, Inc.
Funding: “This study was supported by a research grant from iRhythm Technologies, Inc.”
Role of the funder: “The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation or approval of the manuscript; and decision to submit the manuscript for publication. The funder did provide data from the studied Zio XT patches and also participated in reviewing the manuscript.”
Additional contributions: “We thank Alda I. Inveiss, MPH, Kaiser Permanente Northern California, and Martha Livingston, CRA, iRhythm Technologies, Inc[.], for their expert technical assistance. These individuals were not compensated specifically for their contributions.”
“This study was supported in part by Clinical and Translational Science Award funding to the Scripps Translational Science Institute (National Institutes of Health/National Center for Advancing Translational Sciences UL1 TR000109) and iRhythm Technologies.”
Author affiliations: “Dr. Kumar is the founder and former chief medical officer of iRhythm Technologies, Inc. (San Francisco) and retains a significant equity share in the company.”
Funding: “This project was supported by a grant from iRhythm Technologies, Inc. (San Francisco, CA). Dr. Turakhia is supported by Veterans Health Services Research and Development Career Development Award CDA09027-1 (Washington, DC) and American Heart Association National Scientist Development grant 09SDG2250647 (Dallas, Texas).”
“The research reported in this article was supported by a restricted research grant from iRhythm Technologies, Inc., San Francisco, CA.”
Hear first-hand experiences from physicians using Zio, and how it has impacted patient care and their practices. Each physician brings their unique perspective of clinical use cases. Webinar recordings are available on demand.
RECORDED AUGUST 31, 2022
Mark J. Day, PhD
Chief Technology Officer, iRhythm Technologies
Run Time: 44 Minutes
Hear first-hand experiences from physicians using Zio, and how it has impacted patient care and their practices. Each physician brings their unique perspective of clinical use cases. Webinar recordings are available on demand.
WEB0179.01
